• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).

作者信息

Graham Ian, Atar Dan, Borch-Johnsen Knut, Boysen Gudrun, Burell Gunilla, Cifkova Renata, Dallongeville Jean, De Backer Guy, Ebrahim Shah, Gjelsvik Bjørn, Herrmann-Lingen Christoph, Hoes Arno, Humphries Steve, Knapton Mike, Perk Joep, Priori Silvia G, Pyorala Kalevi, Reiner Zeljko, Ruilope Luis, Sans-Menendez Susana, Scholte op Reimer Wilma, Weissberg Peter, Wood David, Yarnell John, Zamorano Jose Luis, Walma Edmond, Fitzgerald Tony, Cooney Marie Therese, Dudina Alexandra

机构信息

Department of Cardiology, Adelaide and Meath Hospital, Dublin, Ireland.

出版信息

Eur Heart J. 2007 Oct;28(19):2375-414. doi: 10.1093/eurheartj/ehm316. Epub 2007 Aug 28.

DOI:10.1093/eurheartj/ehm316
PMID:17726041
Abstract
摘要

相似文献

1
European guidelines on cardiovascular disease prevention in clinical practice: executive summary: Fourth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (Constituted by representatives of nine societies and by invited experts).欧洲临床实践心血管疾病预防指南：执行摘要：欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第四次报告（由九个学会的代表及特邀专家组成）
Eur Heart J. 2007 Oct;28(19):2375-414. doi: 10.1093/eurheartj/ehm316. Epub 2007 Aug 28.
2
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012). The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第五版（由九个学会的代表及特邀专家组成）。
Eur Heart J. 2012 Jul;33(13):1635-701. doi: 10.1093/eurheartj/ehs092. Epub 2012 May 3.
3
European guidelines on cardiovascular disease prevention in clinical practice: executive summary. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).欧洲临床实践中心血管疾病预防指南：执行摘要。欧洲心脏病学会和其他学会关于临床实践中心血管疾病预防的第四联合工作组（由九个学会的代表和特邀专家组成）。
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:E1-40. doi: 10.1097/01.hjr.0000277984.31558.c4.
4
European guidelines on cardiovascular disease prevention in clinical practice: full text. Fourth Joint Task Force of the European Society of Cardiology and other societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts).欧洲临床实践中心血管疾病预防指南：全文。欧洲心脏病学会及其他学会关于临床实践中心血管疾病预防的第四联合工作组（由九个学会的代表及特邀专家组成）。
Eur J Cardiovasc Prev Rehabil. 2007 Sep;14 Suppl 2:S1-113. doi: 10.1097/01.hjr.0000277983.23934.c9.
5
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts)Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成）由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Eur Heart J. 2016 Aug 1;37(29):2315-2381. doi: 10.1093/eurheartj/ehw106. Epub 2016 May 23.
6
[2016 European guidelines on cardiovascular disease prevention in clinical practice. The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts. Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation].[2016年欧洲临床实践心血管疾病预防指南。欧洲心脏病学会及其他学会心血管疾病预防临床实践联合工作组第六版（由10个学会的代表及特邀专家组成。在欧洲心血管预防与康复协会的特别贡献下制定）]
G Ital Cardiol (Rome). 2017 Jul-Aug;18(7):547-612. doi: 10.1714/2729.27821.
7
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): the Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）：欧洲心脏病学会及其他学会关于临床实践心血管疾病预防的第五联合工作组（由九个学会的代表及特邀专家组成）
Eur J Prev Cardiol. 2012 Aug;19(4):585-667. doi: 10.1177/2047487312450228. Epub 2012 Jul 4.
8
European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of nine societies and by invited experts).《欧洲临床实践心血管疾病预防指南》（2012年版）：欧洲心脏病学会及其他学会临床实践心血管疾病预防联合特别工作组（由九个学会的代表及特邀专家组成）。
Atherosclerosis. 2012 Jul;223(1):1-68. doi: 10.1016/j.atherosclerosis.2012.05.007. Epub 2012 May 14.
9
2016 European Guidelines on cardiovascular disease prevention in clinical practice: The Sixth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice (constituted by representatives of 10 societies and by invited experts) Developed with the special contribution of the European Association for Cardiovascular Prevention & Rehabilitation (EACPR).2016年欧洲临床实践心血管疾病预防指南：欧洲心脏病学会和其他学会关于临床实践心血管疾病预防的第六联合工作组（由10个学会的代表和特邀专家组成），由欧洲心血管预防与康复协会（EACPR）特别贡献制定。
Atherosclerosis. 2016 Sep;252:207-274. doi: 10.1016/j.atherosclerosis.2016.05.037.
10
European guidelines on cardiovascular disease prevention in clinical practice. Third Joint Task Force of European and Other Societies on Cardiovascular Disease Prevention in Clinical Practice.欧洲临床实践中心血管疾病预防指南。欧洲及其他学会心血管疾病预防临床实践联合工作组第三次报告
Eur Heart J. 2003 Sep;24(17):1601-10. doi: 10.1016/s0195-668x(03)00347-6.

引用本文的文献

1
Trends in cardiovascular risk factors in poland: results from the comprehensive cardiovascular risk prevention program.波兰心血管危险因素的趋势：综合心血管疾病预防项目的结果
BMC Public Health. 2025 Aug 29;25(1):2962. doi: 10.1186/s12889-025-24385-6.
2
The Impact of Flavonoids and Omega-3 in Mitigating Frailty Syndrome to Improve Treatment Outcomes in Peripheral Artery Disease (PAD) Patients.类黄酮和欧米伽-3对减轻衰弱综合征以改善外周动脉疾病（PAD）患者治疗效果的影响。
Nutrients. 2025 Jul 12;17(14):2303. doi: 10.3390/nu17142303.
3
Refining Patient Selection Criteria for LV-Only Fusion Pacing in Cardiac Resynchronization Therapy: A Systematic Review.
优化心脏再同步治疗中仅左心室融合起搏的患者选择标准：一项系统评价
J Clin Med. 2025 Jul 8;14(14):4853. doi: 10.3390/jcm14144853.
4
Leptin promoter G2548A variant, elevated plasma leptin levels, and increased risk of Type 2 diabetes with CAD in Iranian patients: A genetic association study.瘦素启动子G2548A变异、血浆瘦素水平升高与伊朗患者2型糖尿病合并冠心病风险增加：一项基因关联研究
J Diabetes Investig. 2025 Sep;16(9):1645-1652. doi: 10.1111/jdi.70077. Epub 2025 Jun 10.
5
Gender and Educational Trends in Lifetime Risk, Age at Onset, Expectancy, and Survival With Cardiovascular Disease in Finland, 1996-2020.1996 - 2020年芬兰心血管疾病终生风险、发病年龄、预期寿命及生存率的性别与教育趋势
J Gerontol B Psychol Sci Soc Sci. 2025 Mar 12;80(4). doi: 10.1093/geronb/gbaf007.
6
Atherogenic Dyslipidemia Is Critically Related to Aortic Complicated Lesions in Cryptogenic Stroke.致动脉粥样硬化性血脂异常与隐源性卒中的主动脉复杂病变密切相关。
J Atheroscler Thromb. 2025 Jul 1;32(7):804-822. doi: 10.5551/jat.65289. Epub 2024 Dec 26.
7
[Pilot programme for screening perimenopausal women for cardiovascular risk from community pharmacy: MENOVASC Project].社区药房围绝经期女性心血管风险筛查试点项目：MENOVASC项目
Farm Comunitarios. 2023 Apr 14;15(3):17-24. doi: 10.33620/FC.2173-9218.(2023).17. eCollection 2023 Jul 15.
8
PCSK9 inhibitors in real life-Cardiometabolic risk management in dyslipidemic patients in Vienna.现实生活中的前蛋白转化酶枯草溶菌素9抑制剂——维也纳血脂异常患者的心脏代谢风险管理
Wien Klin Wochenschr. 2025 May;137(9-10):307-313. doi: 10.1007/s00508-024-02402-9. Epub 2024 Aug 13.
9
Impact of Classical Risk Factors on Subclinical Carotid Atherosclerosis Progression: Insights from a Non-Diabetic Cohort.经典危险因素对亚临床颈动脉粥样硬化进展的影响：来自非糖尿病队列的见解
Rev Cardiovasc Med. 2024 Mar 12;25(3):103. doi: 10.31083/j.rcm2503103. eCollection 2024 Mar.
10
Identification of nutrition factors in the metabolic syndrome and its progression over time in older adults: analysis of the TUDA cohort.老年人代谢综合征中营养因素的识别及其随时间的进展：图达队列分析
Diabetol Metab Syndr. 2024 Jun 8;16(1):125. doi: 10.1186/s13098-024-01367-z.